Disparities in Lung Cancer Death Among People with Chronic Lower Respiratory Diseases in the United States
Lung · 2025
DOI: 10.1007/s00408-024-00756-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lung, 2025. Verfasst von Benjamin Grobman und 2 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA. bgrobman@hms.harvard.edu. Hauptthemen laut MEDLINE: Health Status Disparities, Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Patients with chronic lower respiratory diseases (CLRD) are at a higher risk of lung cancer. Less is known regarding how the risk of CLRD-associated lung cancer death might have changed on a national scale over the past 20 years across demographic and regional groups. METHODS: We calculated age-adjusted mortality rates (AAMR) for lung cancer death among people with CLRD using 1999-2020 data from the CDC WONDER multiple cause of death database. Rates were compared between demographic groups and time periods. RESULTS: Rates of lung cancer death among people with CLRD were highest among White Americans compared to other racial groups. Elevated rates of lung cancer death were seen among men (AAMR = 25.054, 95% CI: 24.960-25.148) and those aged 65 + (AAMR = 44.776, 95% CI: 44.638-44.913) compared to their counterparts. Rates were higher in the Midwest (AAMR ratio = 1.410, 95% CI: 1.401-1.418) and the South (AAMR ratio = 1.290, 95% CI: 1.282-1.298) compared to the Northeast. Rates were elevated in rural areas (AAMR ratio = 1.444, 95% CI: 1.438-1.451). Between 1999 and 2004 and 2016-2020, the AAMR of CLRD-associated lung cancer death decreased from 21.647 (95% CI: 21.528-21.765) to 17.221 (95% CI: 17.123 - 17.318). Rates decreased over time across demographic groups. CONCLUSION: CLRD-associated lung cancer deaths significantly decreased in the United States between 1999 and 2020. Despite this progress, White people, men, older adults (65 +), and people in rural areas continue to experience higher CLRD-associated lung cancer mortality rates than their counterparts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Harvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA. bgrobman@hms.harvard.edu.
- Harvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA.
- Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, MA, 02215, USA.
- School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, 2050, Australia.
- Faculty of Medicine and Health, Kolling Institute, The University of Sydney and the Northern Sydney Local Health District, Sydney, NSW, 2065, Australia.
Zitieren
APA
Grobman, B., Mansur, A., & Lu, C. Y. (2025). Disparities in Lung Cancer Death Among People with Chronic Lower Respiratory Diseases in the United States. Lung. https://doi.org/10.1007/s00408-024-00756-5
Vancouver
Grobman B, Mansur A, Lu CY. Disparities in Lung Cancer Death Among People with Chronic Lower Respiratory Diseases in the United States. Lung. 2025. doi:10.1007/s00408-024-00756-5
BibTeX
@article{Grobman2025,
author = {Grobman, Benjamin and Mansur, Arian and Lu, Christine Y},
title = {Disparities in Lung Cancer Death Among People with Chronic Lower Respiratory Diseases in the United States},
journal = {Lung},
year = {2025},
doi = {10.1007/s00408-024-00756-5}
}
EUVIMED